The Yin and Yang of Sox Proteins: Activation and Repression in Development and Disease

被引:86
作者
Chew, Li-Jin [1 ]
Gallo, Vittorio [1 ]
机构
[1] Childrens Natl Med Ctr, Ctr Res Neurosci, Childrens Res Inst, Washington, DC 20010 USA
关键词
HMG; SOX; development; transcription; Wnt; interactions; TRANSCRIPTION FACTOR; NEURAL CREST; BETA-CATENIN; DOWN-REGULATION; CHONDROCYTE DIFFERENTIATION; OLIGODENDROCYTE DEVELOPMENT; REGULATES CHONDROGENESIS; MOLECULAR-MECHANISM; GENE-EXPRESSION; MOUSE;
D O I
10.1002/jnr.22128
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The general view of development consists of the acquisition of committed/differentiated phenotypes following a period of self-renewal and progenitor expansion. Lineage specification and progression are phenomena of antagonistic events, silencing tissue-specific gene expression in precursors to allow self-renewal and multipotentiality, and subsequently suppressing proliferation and embryonic gene expression to promote the restricted expression of tissue-specific genes during maturation. The high mobility group-containing Sox family of transcription factors constitutes one of the earliest classes of genes to be expressed during embryonic development. These proteins not only are indispensable for progenitor cell specification but also are critical for terminal differentiation of multiple cell types in a wide variety of lineages. Sox transcription factors are now known to induce or repress progenitor cell characteristics and cell proliferation or to activate the expression of tissue-specific genes. Sox proteins fulfill their diverse functions in developmental regulation by distinct molecular mechanisms. Not surprisingly, in addition to DNA binding and bending, Sox transcription factors also interact with different protein partners to function as coactivators or corepressors of downstream target genes. Here we seek to provide an overview of the current knowledge of Sox gene functional mechanisms, in an effort to understand their roles in both development and pathology. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:3277 / 3287
页数:11
相关论文
共 111 条
[11]   New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2 [J].
Botquin, V ;
Hess, H ;
Fuhrmann, G ;
Anastassiadis, C ;
Gross, MK ;
Vriend, G ;
Schöler, HR .
GENES & DEVELOPMENT, 1998, 12 (13) :2073-2090
[12]   Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators [J].
Bowles, J ;
Schepers, G ;
Koopman, P .
DEVELOPMENTAL BIOLOGY, 2000, 227 (02) :239-255
[13]   Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer [J].
Bridgewater, LC ;
Lefebvre, V ;
de Crombrugghe, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (24) :14998-15006
[14]   The transcription factor Sox10 is a key regulator of peripheral glial development [J].
Britsch, S ;
Goerich, DE ;
Riethmacher, D ;
Peirano, RI ;
Rossner, M ;
Nave, KA ;
Birchmeier, C ;
Wegner, M .
GENES & DEVELOPMENT, 2001, 15 (01) :66-78
[15]   Vertebrate neurogenesis is counteracted by Sox1-3 activity [J].
Bylund, M ;
Andersson, E ;
Novitch, BG ;
Muhr, J .
NATURE NEUROSCIENCE, 2003, 6 (11) :1162-1168
[16]  
CARD DAG, 2008, MOL CELL BI IN PRESS
[17]   Protein kinase C regulates chondrogenesis of mesenchymes via mitogen-activated protein kinase signaling [J].
Chang, SH ;
Oh, CD ;
Yang, MS ;
Kang, SS ;
Lee, YS ;
Sonn, JK ;
Chun, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) :19213-19219
[18]   The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer [J].
Chen, Yupeng ;
Shi, Lei ;
Zhang, Lirong ;
Li, Ruifang ;
Liang, Jing ;
Yu, Wenhua ;
Sun, Luyang ;
Yang, Xiaohan ;
Wang, Yan ;
Zhang, Yu ;
Shang, Yongfeng .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (26) :17969-17978
[19]   Neural crest development is regulated by the transcription factor Sox9 [J].
Cheung, M ;
Briscoe, J .
DEVELOPMENT, 2003, 130 (23) :5681-5693
[20]   Sox6 regulation of cardiac myocyte development [J].
Cohen-Barak, O ;
Yi, ZH ;
Hagiwara, N ;
Monzen, K ;
Komuro, I ;
Brilliant, MH .
NUCLEIC ACIDS RESEARCH, 2003, 31 (20) :5941-5948